Linda Beauclair
Assistant Professor
Psychiatry
McGill University
Canada
Biography
Dr. Beauclair is the Director of the Clinical Psychopharmacology and Therapeutics Unit. She is conducting clinical trials with the purpose of developing new treatments in schizophrenia, depression, and panic disorders. She is also involved in the training and the teaching of residents in psychiatry and the residents in the Royal College of Physicians and Surgeons of Canada’s Accredited Residency Program in Clinical Pharmacology at McGill University.
Research Interest
Psychopharmacology
Publications
-
Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the electronic Schizophrenia Treatment Adherence Registry in Canada. Williams R, Chandrasena R, Beauclair L, Luong D, Lam A.
-
Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia. Desmarais JE, Beauclair L, Annable L, Bélanger MC, Kolivakis TT, Margolese HC.
-
Mariner Transposons Contain a Silencer: Possible Role of the Polycomb Repressive Complex 2. Bire S, Casteret S, Piégu B, Beauclair L, Moiré N, Arensbuger P, Bigot Y.
